9:22 AM
Leo Group India
| ||
| Dishman Pharmaceuticals & Chemicals Ltd's net profit up by 155% Economic Times Dishman is one of the four major Contract Research and Manufacturing Services ( CRAMS) companies in India, engaged mainly into manufacturing of active pharmaceutical ingredients ( API). On Tuesday, Dishman's stock surged by 6.74% closing at Rs ... See all stories on this topic » | ||
| Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results MarketWatch (press release) MALVERN, Pa., July 31, 2012 /PRNewswire via COMTEX/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) , a specialty biopharmaceutical company, today announced financial results for the quarter ending on June 30, 2012. The Company also highlighted ... See all stories on this topic » | ||
| Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors Sacramento Bee DUBLIN, July 30, 2012 -- /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of Catherine Angell Sohn, Pharm.D., CLP, to its board of directors at the company's annual meeting of shareholders held on July 27, 2012. See all stories on this topic » | ||
| Idenix Pharmaceutical gets Fast Track designation with New Hepititis C Virus ... Express Pharma Idenix Pharmaceuticals, the Cambridge-based biotechnology company, announced that its drug, IDX719, was granted a Fast Track designation by the FDA. IDX719, an NS5A inhibitor, is designed to treat chronic hepatitis C virus (HCV) infection in patients. See all stories on this topic » | ||
| Ohr Pharmaceutical Issues Letter to Shareholders MarketWatch (press release) NEW YORK, NY, Jul 31, 2012 (MARKETWIRE via COMTEX) -- Ohr Pharmaceutical Inc. (OBB:OHRP) , a pharmaceutical company dedicated to developing novel treatments for large unmet medical needs, issued the following letter to shareholders today: ... See all stories on this topic » | ||
| Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings ... Seeking Alpha Tom Marks. Acura Pharmaceuticals (ACUR) Q2 2012 Earnings Call July 31, 2012 8:30 AM ET. Operator. Good day, everyone, and welcome, ladies and gentlemen, to the Acura Pharmaceutical's Conference Call. As a reminder, today's call is being recorded. See all stories on this topic » | ||
| Transcept Pharmaceuticals to Report Second Quarter 2012 Financial Results ... Sacramento Bee POINT RICHMOND, Calif., July 30, 2012 -- /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic ... See all stories on this topic » | ||
| AmerisourceBergen Signs Three Year Pharmaceutical Supply Agreement with ... MarketWatch (press release) "We are honored that Express Scripts has chosen AmerisourceBergen to supply the brand pharmaceuticals it needs for its recently combined mail order and specialty pharmacy business," said Steven H. Collis, AmerisourceBergen President and Chief ... See all stories on this topic » | ||
| Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings ... TheStreet.com Hologic Management Discusses Q3 2012 Results - Earnings Call Transcript. Good day, everyone, and welcome, ladies and gentlemen, to the Acura Pharmaceutical's Conference Call. As a reminder, today's call is being recorded. [Operator Instructions] At this ... See all stories on this topic » | ||
| Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2012 ... MarketWatch (press release) PARSIPPANY, N.J., Jul 31, 2012 (BUSINESS WIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that financial results for the company's second quarter ended June 30, 2012, will be released before the market opens on Thursday, ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment